Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAIREA Regulatory News (AIEA)

Share Price Information for AIREA (AIEA)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £10.80m
AIEA Live PriceLast checked at - London Stock Exchange

Intraday AIREA Share Chart

Amendment - Form 8 (OPD) JAMES HALSTEAD PLC

18 Apr 2018 17:50

RNS Number : 3865L
James Halstead PLC
18 April 2018
Β 

This replaces RNS 3633L that was released in error.

Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

JAMES HALSTEAD PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

JAMES HALSTEAD PLC

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

17/04/2018

Β 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - AIREA PLC

Β 

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary shares of 25 pence each

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Cash-settled derivatives:

Β 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

Β 

TOTAL:

0

0

0

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

Beneficial holdings of the Directors of James Halstead plc and their close relatives and related trusts in James Halstead plc shares:

Β 

Name No. of ordinary shares % of ordinary shares held

Directors

Β 

Anthony Wild 150,300 0.07%

Mark Halstead 35,496,778 17.01%

Gordon Oliver 207,550 0.10%

Steve Hall 5,700 0.00%

Michael Halstead 1,814,234 0.87%

Russell Whiting Nil -

Β 

Β 

Interests of Directors of James Halstead plc (and their close relatives and related trusts) in James Halstead plc share options/awards in respect of ordinary shares

Director

Plan

Number

Date of grant

Exercise price

Date exercisable

Date of expiry

Mark Halstead

Executive share option scheme

80,000

6 October 2008

105.25

6 October 2011

5 October 2018

Mark Halstead

Executive share option scheme

20,000

21 July 2014

270.29

21 July 2017

20 July 2024

Mark Halstead

Executive share option scheme

50,000

12 June 2017

476.50

12 June 2020

11 June 2024

Gordon Oliver

Executive share option scheme

20,000

21 July 2014

270.29

21 July 2017

20 July 2024

Gordon Oliver

Executive share option scheme

50,000

12 June 2017

476.50

12 June 2020

11 June 2027

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Interest held by persons deemed to be acting in concert with James Halstead plc

Β 

Panmure Gordon (UK) Limited

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

Β 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

Β 

Arden Partners

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

Β 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

NONE

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

NONE

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

18/04/2018

Contact name:

David Drillingcourt

Telephone number:

0161 767 2500

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEUWSNRWNASAAR
Date   Source Headline
15th Nov 20217:00 amRNSChange of Auditor
7th Sep 20213:40 pmRNSHolding(s) in Company
30th Jul 20217:00 amRNSInterim Report
24th Jun 202112:22 pmRNSHolding(s) in Company
19th May 20213:34 pmRNSAppointment of Director and Company Secretary
12th May 20213:59 pmRNSResult of AGM
29th Apr 20215:04 pmRNSHolding(s) in Company
29th Apr 20214:50 pmRNSHolding(s) in Company
21st Apr 202111:39 amRNSHolding(s) in Company
15th Mar 20211:58 pmRNSDirectorate Change
4th Mar 20217:30 amRNSFinal results for the year ended 31 December 2020
30th Jul 20207:00 amRNSInterim Report
14th May 20202:17 pmRNSResult of AGM
1st May 20205:07 pmRNSAnnual General Meeting update
26th Mar 202012:18 pmRNSCovid-19 trading update, dividend and AGM
5th Mar 20205:47 pmRNSTypo correction to Final Results
5th Mar 20207:00 amRNSFinal results for the year ended 31 December 2019
14th Nov 20191:52 pmRNSGrant of Options
5th Aug 201910:47 amRNSHolding(s) in Company
2nd Aug 20197:00 amRNSInterim report for the six months ended 30 June 19
9th May 20193:20 pmRNSResult of AGM
5th Apr 201911:42 amRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSPreliminary Results
4th Feb 20197:00 amRNSTrading Update
17th Aug 20187:00 amRNSHalf-year Report
25th Jul 201812:00 pmRNSDirectorate Change
2nd Jul 20183:21 pmRNSDirectorate Change
26th Jun 201811:30 amRNSDirectorate Change
25th Jun 20184:57 pmRNSHolding(s) in Company
24th May 201810:15 amRNSForm 8.5 (EPT/RI) AIREA Plc
24th May 201810:05 amRNSForm 8.5 (EPT/RI) AIREA Plc
23rd May 201810:04 amRNSForm 8.5 (EPT/RI) AIREA Plc
22nd May 20185:05 pmRNSStatement Regarding James Halstead plc
22nd May 20184:58 pmRNSRule 2.8 Announcement
22nd May 20189:03 amRNSForm 8.5 (EPT/RI) AIREA Plc
21st May 20189:44 amRNSForm 8.5 (EPT/RI) AIREA Plc
17th May 201810:05 amRNSForm 8.5 (EPT/RI) AIREA Plc
16th May 20189:54 amRNSForm 8.5 (EPT/RI) AIREA Plc
15th May 20188:58 amRNSForm 8.5 (EPT/RI) AIREA Plc
14th May 20189:51 amRNSForm 8.5 (EPT/RI) AIREA Plc
11th May 20185:01 pmRNSResult of AGM
11th May 20189:33 amRNSForm 8.5 (EPT/RI) AIREA Plc
10th May 20181:30 pmRNSForm 8.3 - Jean Burrows - Airea plc
10th May 20189:23 amRNSForm 8.5 (EPT/RI) AIREA Plc
9th May 20183:29 pmBUSForm 8.3 - Airea Plc
9th May 20189:42 amRNSForm 8.5 (EPT/RI) AIREA Plc
8th May 20188:27 amRNSForm 8.5 (EPT/RI) AIREA Plc
4th May 201810:18 amRNSForm 8.5 (EPT/RI) AIREA Plc
4th May 201810:12 amRNSForm 8.3 - Airea PLC
3rd May 20189:29 amRNSForm 8.5 (EPT/RI) AIREA Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.